News Sentiment

1276 sentiment intelligence

Jiangsu Hengrui Pharmaceuticals Co.,Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 54 Balanced news tone 19 relevant articles
Exchange HKG Hong Kong
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 59.25 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 19

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend inactive

-1.1% over one week, +7.4% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Hengrui Pharma shares surge on $1 bln Bristol-Myers partnership

Market Reaction

Balanced read

63/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction -1.1% Price digesting
Trend fit Trend inactive 7.4% over four weeks
Fair value -14.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 14
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 19
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
South China Morning Post 5
Bloomberg.com 2
Reuters 2
Investing.com 1
BioWorld News 1
Fierce Pharma 1
ETPharma.com 1
Law.asia 1

Event Lens

What the news is about

Classified themes
Market update 11
Deals and strategy 7
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-19 of 19